Smiths Medical won 501(k) clearance from the FDA for its CADD-Solis infusion pump, indicated to help treat pain.
Smiths hopes to market the device for use in post-operation pain management as well as for delivery of epidural analgesia during labor and delivery, the company said.
The new CADD-Solis includes updated software with the company’s Programmed Intermittent Bolus and Patient Controlled Analgesics software, features that Smiths says will aid doctors in providing care for patients during labor or after surgery.
“The new CADD-Solis system with PIB [programmed intermittent bolus] and PCA [patient controlled analgesics] combines programmed intermittent boluses and patient-controlled doses in an integrated, innovative delivery system," global product management vice president Tommy Johns said in prepared remarks. "The PIB programming parameters and the delivery pressure provided by the CADD-Solis system offer flexible drug delivery and reliable distribution of medication, which can help overcome some of the challenges associated with epidural analgesia."